Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of the present study is to develop a measurement protocol for optimal imaging of the anterior segment of the eye, including anterior chamber angle, Schlemm's canal, filtering bleb and pseudoexfoliation deposits on the lens based on measurements in patients with glaucoma and PEX. In glaucoma the structures of the anterior chamber are important for classification, therapy, progression and prognosis and imaging of the angle between the iris and the cornea is the key for open angle and closed angle glaucoma differential diagnosis. For this purpose, a customized ultrahigh resolution Spectral Domain OCT will be used to validate whether the protocol can also be more widely applied in these patients. Based on the obtained measurement protocol, further studies investigating anatomy and pathophysiology of the anterior segment of the eye as well as surgical outcome in patients with glaucoma and PEX can be planned.
The aim of the study is to develop a measurement protocol for OCT imaging and characterization of the anterior chamber in glaucoma patients.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| primary open angle glaucoma patients | No Intervention | ||
| patients with primary angle closure | No Intervention | ||
| patients with neovascular glaucoma | No Intervention | ||
| PEX glaucoma patients | No Intervention | ||
| glaucoma patients with filtering bleb | No Intervention | ||
| healthy volunteers | Experimental | instillation of antiglaucoma treatment in the study eye |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Pilocarpine | Drug | topical instillation into the study eye |
|
| Measure | Description | Time Frame |
|---|---|---|
| 3-dimensional imaging of the anterior eye segment | 1 day |
Not provided
Not provided
Inclusion Criteria:
For patients with primary open angle glaucoma:
For patients with primary angle closure:
For patients with neovascular glaucoma:
- Neovascularization in the anterior chamber angle
For patients with pseudoexfolation deposits on the lens:
For glaucoma patients with filtering bleb after trabeculectomy:
For healthy volunteers:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Gerhard Garhöfer, Assoc. Prof. PD Dr. | Contact | 0043140400 | 29810 | gerhard.garhoefer@meduniwien.ac.at |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of Clinical Pharmacology, Medical University of Vienna | Recruiting | Vienna | 1090 | Austria |
Not provided
| ID | Term |
|---|---|
| D005901 | Glaucoma |
| ID | Term |
|---|---|
| D009798 | Ocular Hypertension |
| D005128 | Eye Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D010862 | Pilocarpine |
| ID | Term |
|---|---|
| D000470 | Alkaloids |
| D006571 | Heterocyclic Compounds |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided